Naltrexone HCl/Bupropion HCl Placebo
NaltrexBuprop-4004
Approved small_molecule terminated
Quick answer
Naltrexone HCl/Bupropion HCl Placebo for Weight Regain Post Bariatric Surgery is a Approved program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Weight Regain Post Bariatric Surgery
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated